RadNet Reports Record First Quarter Financial Results and Revises Upwards 2026 Imaging Center Financial Guidance Ranges for Revenue, Adjusted EBITDA and Free Cash Flow Total Company Revenue increase

RadNet Reports Record First Quarter Financial

Results and Revises Upwards 2026 Imaging Center Financial Guidance Ranges for Revenue, Adjusted EBITDA and Free Cash Flow

LOS ANGELES, California, May 10, 2026 - RadNet,

Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services

through a network of 435 outpatient imaging centers and a premier developer of radiology digital health solutions, today reported financial

results for its first quarter of 2026.

Dr. Howard Berger, President and Chief Executive Officer

of RadNet, commented, "After being impacted by severe winter weather conditions in the Northeast during January and February which

reduced Revenue and Adjusted EBITDA(1) by an estimated $13 million and $9 million, respectively, our business strongly rebounded

in March, resulting in a Total Company Revenue increase of 22.1% and a Total Company Adjusted EBITDA(1) increase of 36.3% from

last year's first quarter. The record first quarter performance was driven by aggregate advanced imaging (MRI, CT and PET/CT) growth

of 19.7% and same-center advanced imaging growth of 8.2% as compared with the first quarter of last year. The growth in MR, CT and PET/CT

contributed to a 235 basis point shift in RadNet's advanced imaging procedural volume mix (relative to routine imaging) as compared

with the same quarter last year, increasing from 26.9% in last year's first quarter to 29.3% in the first quarter of 2026. Imaging

Center Adjusted EBITDA(1) margin increased by 52 basis points, after adjusting for lost Revenue and Adjusted EBITDA(1)

from the severe winter weather in this year's first quarter and the severe winter weather and California wildfires in last year's

Dr. Berger continued, "On April 30th, we announced

the commencement of a new health system joint venture with Trinity Health's Saint Alphonsus Health System initially with five outpatient

imaging centers in Boise, Idaho. In conjunction with this new partnership, various modules of DeepHealth OS as well as AI-powered solutions

for radiologist reporting, patient engagement and clinical interpretation will be implemented. This relationship is a blueprint for future

health system partnerships, where RadNet can bring all of its operational, clinical and digital workflow solutions to bear to streamline

the patient journey and improve medical care and outcomes. As a result of the strong operating trends during the first quarter which have

continued through early May, we are increasing 2026 Imaging Center guidance for Revenue, Adjusted EBITDA(1) and Free Cash Flow(2)."

"The Digital Health division continues to gain

momentum, which was further advanced with the March 2, 2026 acquisition of Gleamer SAS in France. DeepHealth's clinical AI portfolio

now includes interpretive solutions in virtually all imaging modalities. We estimate that by the end of this year, over 70% of RadNet

studies could be running through clinical AI, and we expect that all of RadNet's radiologist reports will be processed through DeepHealth's

Reporting Pro AI-powered auto-impression/summarization engine. When fully implemented, these initiatives should result in significant

enhancement to patient care and workflow productivity intended to achieve a measurable improvement to RadNet's operating expenses.

Furthermore, the Digital Health sales pipeline with third-party customers continued to build during the first quarter, during which we

signed over $16 million (Total Contract Value) of new DeepHealth business. These contracts span the full breadth of DeepHealth products

including clinical AI, operating and diagnostic workflow and TechLive solutions," added Dr. Berger.

"RadNet's balance sheet continues to be

among the strongest in the diagnostic imaging industry. At quarter end, which reflected the acquisition of Gleamer and recent imaging

center transactions, we had a cash balance of $455.3 million and a leverage ratio of Net Debt to Adjusted EBITDA(1) of slightly

below 2.0. Financial leverage and liquidity will continue to be carefully managed to maintain optimal future operating flexibility,"

concluded Dr. Berger.

For the first quarter of 2026, RadNet reported Total

Company Revenue of $575.6 million and Adjusted EBITDA(1) of $63.3 million. Revenue increased $104.2 million (or 22.1%) and

Adjusted EBITDA(1) increased $16.9 million (or 36.3%) as compared with the first quarter of 2025.

For the first quarter of 2026, RadNet reported Digital

Health Revenue (inclusive of intersegment revenue) of $29.1 million and Adjusted EBITDA(1) of $1.3 million. Revenue increased

$9.9 million (or 51.5%) and Adjusted EBITDA(1) decreased $2.4 million as compared with the first quarter of 2025. At March

31, 2026, Annual Recurring Revenue(4) (ARR) for Digital Health was $96.9 million, as compared with $49.8 million as of March

There were a number of unusual or one-time items impacting

the first quarter including: $0.9 million expense related to leases for de novo facilities under construction that have yet to open their

operations; $3.5 million of acquisition transaction costs; $2.6 million loss on the sale and disposal of equipment; $1.5 million of severance

costs; $2.8 million change in contingent consideration related to past acquisitions; and $4.6 million of non-capitalized research and

development expenses with respect to DeepHealth Cloud OS and generative AI. Adjusting for the above items, Total Company Adjusted Loss(3)

was $21.6 million and diluted Adjusted Loss Per Share(3) was $(0.28) for the first quarter of 2026. This compares with Total

Company Adjusted Loss(3) of $25.2 million and diluted Adjusted Loss Per Share(3) of $(0.34) during the first quarter

Unadjusted for unusual or one-time items impacting

the first quarter of 2026, Total Company Net Loss for the first quarter of 2026 was $33.5 million as compared with a Total Company Net

Loss of $37.9 million for the first quarter of 2025. Net Loss Per Share for the first quarter of 2026 was $(0.43), compared with a Net

Loss per share of $(0.51) in the first quarter of 2025, based upon a weighted average number of diluted shares outstanding of 77.1 million

shares in 2026 and 74.4 million shares in 2025.

For the first quarter of 2026, as compared with the

prior year's first quarter, MRI volume increased 20.3%, CT volume increased 17.7% and PET/CT volume increased 35.2% on a systemwide

basis (including unconsolidated joint venture centers). Overall volume, taking into account routine imaging exams, inclusive of x-ray,

ultrasound, mammography and other exams, increased 10.1% over the prior year's first quarter. On a same-center systemwide basis,

including only those centers which were part of RadNet for both the first quarters of 2026 and 2025, MRI volume increased 10.0%, CT volume

increased 4.7% and PET/CT volume increased 14.7%. Overall same-center volume, taking into account routine imaging exams, inclusive of

x-ray, ultrasound, mammography and other exams, increased 2.4% over the prior year's same quarter.

2026 Revised Guidance

RadNet amends its previously announced guidance levels

Imaging Center Segment

Digital Health Segment

Financial Results Conference Call

Dr. Howard Berger, President and Chief Executive Officer,

and Mark Stolper, Executive Vice President and Chief Financial Officer, will host a conference call to discuss its first quarter 2026

results on Monday, May 11th, 2026 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).

Conference Call Details:

Date: Monday, May 11, 2026

Time: 10:30 a.m. Eastern Time

Dial In-Number: 844-744-1280

International Dial-In Number: 412-564-6465

It is recommended that

participants dial in approximately 5 to 10 minutes prior to the start of the 10:30 a.m. call. There will also be simultaneous and archived

webcasts available at https://viavid.webcasts.com/starthere.jsp?ei=1761306&tp_key=ea5d61284c

or http://www.radnet.com under the "Investors" menu section and "News Releases"

sub-menu of the website. An archived replay of the call will also be available and can be accessed by dialing 844-512-2921 from the U.S.,

or 412-317-6671 for international allers, and using the passcode 10208825.

RadNet, Inc. is a leading national

provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging

revenue. RadNet has a network of owned and/or operated outpatient imaging centers. RadNet's imaging center markets include Arizona,

California, Delaware, Florida, Idaho, Indiana, Maryland, New Jersey, New York, Texas and Virginia. In addition, RadNet provides radiology

information technology and artificial intelligence solutions marketed under the DeepHealth brand, teleradiology professional services

and other related products and services to customers in the diagnostic imaging industry globally. Together with contracted radiologists,

and inclusive of full-time and per diem employees and technologists, RadNet has over 11,000 team members. Learn more at radnet.com.

Forward Looking Statements

This press release contains

"forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform

Act of 1995. Forward-looking statements are expressions of our current beliefs, expectations and assumptions regarding the future of our

business, future plans and strategies, projections, and anticipated future conditions, events and trends. Forward-looking statements can

generally be identified by words such as: "anticipate," "intend," "plan," "goal," "seek,"

"believe," "project," "estimate," "expect," "strategy," "future,"